Retatrutide is a robust triple-agonist (GLP-1 + GIP + Glucagon) that induces significantly greater weight loss and metabolic rate increases in early trials
Gastric banding: An adjustable silicone band filled with saline is wrapped around a part of the stomach, creating a small pouch that restricts the intake of food
Tesamorelin offers powerful, clinically proven visceral fat reduction and metabolic improvement, while sermorelin provides a gentler, broader approach to anti-aging, sleep, recovery, and hormonal balance
BMC Public Health (2009) 9:88
BioMed Res Int (2021) 2021:3361309
Short-acting GLP-1 receptor agonists include exenatide (Byetta, with limited US availability) and lixisenatide (Adlyxin, discontinued in the US market)